Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 3/20 | 0.55 |
| ▸ | CTSK | P43235 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.54 |
| ▸ | CTSL | P07711 | 3/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25973070 | 1.00 | CTSS (0.55) | CTSSCTSKOPRD1OPRM1OPRK1 | |
| SCHEMBL27101824 | 0.90 | CTSS (0.53) | CTSSCTSKOPRD1OPRM1OPRK1 | |
| SCHEMBL29330070 | 0.89 | CTSS (0.52) | CTSSCTSKOPRD1OPRM1OPRK1 | |
| SCHEMBL18513842 | 0.89 | CTSS (0.54) | CTSSCTSKOPRD1OPRM1OPRK1 | |
| SCHEMBL4847121 | 0.87 | FCER2 (0.58) | CTSSCTSKOPRD1OPRM1OPRK1 | |
| SCHEMBL4847134 | 0.87 | FCER2 (0.58) | CTSSCTSKOPRD1OPRM1OPRK1 | |
| SCHEMBL26559151 | 0.86 | OPRM1 (0.51) | CTSSCTSKOPRD1OPRM1OPRK1 | |
| SCHEMBL11191376 | 0.86 | ACE (0.56) | CTSSCTSKL3MBTL1 | |
| SCHEMBL11191380 | 0.86 | ACE (0.56) | CTSSCTSKL3MBTL1 | |
| SCHEMBL24504162 | 0.86 | OPRD1 (0.64) | CTSSCTSKOPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023006084-A1 | ANTI-DLL3 ANTIBODY AND PREPARATION METHOD THEREFOR, DRUG CONJUGATE AND APPLICATION THEREOF | 上海复旦张江生物医药股份有限公司 | 2023-02-02 | — | — | WO | disclosed |